Beurer debuts bluetooth upper arm blood pressure monitorsBeurer is introducing its newest Bluetooth Blood Pressure Monitors, the BM82, BM92 and BC54W. CVS Health Ventures makes investment in Amalgam RxThe investment supports the scaling of Amalgam’s EHR solutions. NACDS praises Senate Finance Committee’s bipartisan press toward PBM Reform NACDS emphasized that Congressional action needs to address the needs of Americans on Medicare, Medicaid and their pharmacies. NCPA survey: Chain pharmacy closures an opportunity and threat for independents The NCPA survey also addresses updated COVID-19 vaccines, OTC naloxone, drug shortage and staffing issues. Alvotech, Kashiv BioSciences enter licensing agreement for proposed Xolair biosimilar Xolair, which contains omalizumab, is indicated for diseases such as severe persistent allergic asthma, chronic rhinosinusitis with nasal polyps and chronic spontaneous urticaria. Boehringer Ingelheim offers interchangeable biosimilar to Humira Adalimumab-adbm is approved to treat multiple chronic inflammatory diseases and will be priced at an 81% discount to Humira. Kroger Health Nourishing Change Summit convenes leaders, advances Food as Medicine movement Leaders from various fields focused on food and nutrition and ways to change the way America eats. Retailers offer updated COVID-19, flu and RSV vaccines Retailers, including Hy-Vee, Albertsons and Walgreens, are offering the updated COVID-19 vaccines, flu and RSV shots. Xiromed debuts generic Rozerem Generic Rozerem is used for the treatment of insomnia characterized by difficulty with sleep onset. Padagis will not seek FDA approval for generic Phexxi until Evofem's patents expire The latest-expiring Phexxi patents do not expire until 2033. First Previous 69 70 71 72 73 Next Last
